High burden of non-adherence to blood pressure-lowering medications: meta-analysis of data from over 34,000 adults with hypertension in Sub-Saharan Africa
Leopold Ndemnge Aminde,Valirie Ndip Agbor,Noah Takah Fongwen,Calypse A Ngwasiri,Clovis Nkoke,Miriam A. M. Nji,Anastase Dzudie,Aletta E. Schutte
DOI: https://doi.org/10.1101/2024.05.28.24308082
2024-05-29
Abstract:Introduction: Non-adherence to blood pressure (BP)-lowering medication is a strong predictor of poor BP control. Sub-Saharan Africa (SSA) has extremely low BP control rates (~10%), but it is unclear what the burden of medication non-adherence among Africans with hypertension is. This systematic review estimated the prevalence and determinants of non-adherence to BP-lowering medications in SSA.
Methods: Multiple databases were searched from inception to 6 December 2023. Two reviewers performed independent screening, extraction, and quality assessment of studies. We pooled the prevalence estimates using random effects meta-analyses and summarized the determinants using a narrative synthesis.
Results: From the 1,307 records identified, we included 95 studies published between 1995 and 2023. The overall prevalence of non-adherence to BP-lowering medication among 34,102 people treated for hypertension in 27 countries was 43.5% (95% confidence interval 39.4 to 47.6; I2 = 98.3%). There was no change in the prevalence of non-adherence over time. The burden of non-adherence varied by measurement method (p = 0.028) and by median age (38.8%, > 57 years vs. 47.9%, ≤ 57 years; p = 0.015). Socioeconomic and patient-related factors were the most frequent factors that influenced medication adherence. Active patient participation in management, accurate perceptions, and knowledge of hypertension and its treatment predicted good medication adherence, whereas high pill burden, medication cost, side effects, and comorbidities predicted poor adherence.
Conclusions: With the African population projected to increase from 1.4 to ~2.5 billion by 2050, targeted strategies are urgently needed to optimise medication adherence in people with hypertension in SSA.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the burden of non - adherence to antihypertensive drugs and its determinants among hypertensive patients in Sub - Saharan Africa (SSA). Specifically, the study aims to answer the following two main questions:
1. **What is the burden of non - adherence to antihypertensive drugs among current hypertensive patients in Sub - Saharan Africa? Has this burden changed over time?**
- Through systematic review and meta - analysis, the study estimated the overall prevalence of non - adherence to antihypertensive drugs among hypertensive patients in Sub - Saharan Africa and explored whether this prevalence has changed over time.
2. **What are the determinants that affect the adherence to antihypertensive drugs among hypertensive patients in Sub - Saharan Africa?**
- By comprehensively analyzing the results of multiple studies, the study summarized various factors that affect the adherence to antihypertensive drugs, including socioeconomic factors, patient - related factors, treatment - related factors, and medical team/health system - related factors.
### Main findings
- **Overall prevalence of non - adherence**:
- The overall prevalence of non - adherence to antihypertensive drugs among hypertensive patients in Sub - Saharan Africa is 43.5% (95% confidence interval: 39.4% to 47.6%), and there is significant heterogeneity among different studies (I² = 98.3%).
- The prevalence of non - adherence has not changed significantly over time.
- **Determinants of non - adherence**:
- **Socioeconomic factors**: Lower education level, unemployment, lower income, lack of family or friend support, long distance from medical institutions, high drug costs, and insufficient drug supply are all related to non - adherence.
- **Patient - related factors**: Young adults, insufficient understanding of hypertension, insufficient knowledge of symptom management and treatment, misperception of the health risks of hypertension, comorbidities, alcohol and tobacco use, high stress, and forgetfulness are all related to non - adherence.
- **Treatment - related factors**: High pill burden (taking two or more antihypertensive drugs per day), drug side effects, long diagnosis and treatment time are all related to non - adherence.
- **Medical team/health system - related factors**: Poor doctor - patient relationship, not receiving health education or counseling are also related to non - adherence.
### Conclusion
The study points out that as Africa's population is expected to increase to approximately 2.5 billion by 2050, there is an urgent need to develop targeted strategies to optimize drug adherence among hypertensive patients in Sub - Saharan Africa to prevent hypertension - related health and economic consequences.